NEWSROOM

Category: Validation

Every SaaS release triggers the same validation question: re-test everything or document the update? This CSA playbook shows how to assess vendor releases, select the right regression tier, and maintain a defensible validated state.
Choosing a CMMS or EAM implementation model in a GMP environment is not just a project management decision — it determines where validation effort, operational strain, and compliance risk land across your go-live. In this guide, you’ll compare big-bang, phased, compliance-first, and patchwork approaches to identify the implementation model that best fits your data readiness, QA bandwidth, and audit pressure.
CMMS and EAM implementations rarely stall because of the core system. They stall because integration scope expands faster than teams expect. Learn how to decide which interfaces belong in Phase 1, which can wait, and how to protect your go-live date.
What must be true before a validated CMMS or EAM system goes live? This practical checklist separates the non-negotiable compliance controls from the capabilities you can safely implement later — and shows how to defend your go-live decision under audit.
Why some CMMS validation projects finish in four months while others take a year. Learn how risk-based Computer Software Assurance (CSA) cuts validation effort without increasing compliance risk.
Most RFPs say “must be 21 CFR Part 11 compliant,” but that phrase is meaningless without specifics. This checklist gives you testable demo criteria for Part 11 controls, audit trails, validation support, cybersecurity, mobile/offline workflows, and integration traceability—so you can score vendors on evidence, not marketing claims.
Purpose-built life sciences EAM/CMMS platforms don’t just manage work orders — they reduce the compliance workload that comes with validation, upgrades, and audit readiness. Here’s what “purpose-built” really means for Part 11 controls, maintenance and calibration, and time-to-value.
Predictive signals are reshaping GMP maintenance. These seven metrics—PM compliance, OOT velocity, MTBF trends, and more—help you spot risks months before audits and show clear progress toward quality maturity. Learn how to track, interpret, and act
How risk-based asset management demonstrates FDA Quality Management Maturity. GAMP 5/CSA framework, ICH Q9/Q10, and leading indicator strategies.
How cloud-native EAM/CMMS platforms embed compliance controls for data integrity, mobile workflows, and audit readiness. Includes 7-point checklist with demo tests.

Subscribe for Updates

"*" indicates required fields

You can update your preferences or unsubscribe at any time. By submitting, you agree that Blue Mountain may store and process your information to provide the requested content. Read our Privacy Policy.
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form